Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Additives to Lidocaine for Peribulbar Block in Vitreoretinal Surgery
NCT07519694Not yet recruiting
- Sponsor
- Sohag University
- Start
- May 2026
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of midazolam and cisatracurium (3 arms), sponsored by Sohag University. Primary endpoint: Onset of Akinesia. Planned start May 2026; status: not yet recruiting.
02
Drugs
midazolamcisatracurium
Beyond the preview
Go deeper on NCT07519694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07519694.